Cargando…
Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway
Osteoblastoma is a bone forming tumor with histological features highly similar to osteoid osteoma; the discrimination between the tumor types is based on size and growth pattern. The vast majority of osteoblastomas are benign but there is a group of so-called aggressive osteoblastomas that can be d...
Autores principales: | Nord, Karolin H., Nilsson, Jenny, Arbajian, Elsa, Vult von Steyern, Fredrik, Brosjö, Otte, Cleton-Jansen, Anne-Marie, Szuhai, Karoly, Hogendoorn, Pancras C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827481/ https://www.ncbi.nlm.nih.gov/pubmed/24236197 http://dx.doi.org/10.1371/journal.pone.0080725 |
Ejemplares similares
-
Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma
por: Saba, Karim H, et al.
Publicado: (2020) -
Scattered genomic amplification in dedifferentiated liposarcoma
por: Mandahl, Nils, et al.
Publicado: (2017) -
Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
por: Hofvander, Jakob, et al.
Publicado: (2018) -
Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families
por: Jennes, Ivy, et al.
Publicado: (2011) -
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015)